DOCSLIB.ORG

2013 Quick Reference Magnet

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2013 Quick Reference Magnet H5697--Reportable Disease Magnet-PMS 131 and Black_Layout 1 7/26/2013 2:05 PM Page 1 Quick Reference Reporting Requirements for Communicable Diseases and Work-Related Conditions (see New Jersey Administrative Code Title 8, Chapters 57 and 58) Communicable Disease Service Health care providers required to report: physicians, advanced practice Disease Reporting Requirements and nurses, physician assistants, and certified nurse midwives. Regulations can be viewed at: Administrators required to report: persons having control or supervision http://nj.gov/health/cd/reporting.shtml over a health care facility, correctional facility, school, youth camp, child care center, preschool, or institution of higher education. Laboratory directors: For specific reporting guidelines, see NJAC 8:57-1.7. CONFIRMED or SUSPECT CASES REPORTABLE WITHIN 24 HOURS REPORTABLE DIRECTLY to TELEPHONE IMMEDIATELY to the OF DIAGNOSIS to the the NEW JERSEY LOCAL HEALTH DEPARTMENT LOCAL HEALTH DEPARTMENT DEPARTMENT OF HEALTH l Anthrax l Amoebiasis Hepatitis C , acute and chronic, newly l Botulism l Animal bites treated for rabies diagnosed cases only l Brucellosis l Arboviral diseases Written report within 24 hours l Diphtheria l Babesiosis l Foodborne intoxications (including, but l Campylobacteriosis HIV/AIDS not limited to, ciguatera, paralytic shellfish l Cholera 609-984-5940 or 973-648-7500 poisoning, scombroid, or mushroom l Creutzfeldt-Jakob disease Written report within 24 hours l Cryptosporidiosis poisoning) l AIDS l l Cyclosporiasis Haemophilus influenzae , invasive disease l HIV infection l l Diarrheal disease (child in a day care center Hantavirus pulmonary syndrome l Child exposed to HIV perinatally l Hepatitis A, acute or a foodhandler) l l Ehrlichiosis Influenza, novel strains only Sexually Transmitted Diseases l l Escherichia coli , shiga toxin producing strains Measles 609-826-4869 l (STEC) only Meningococcal invasive disease Report within 24 hours l Outbreak or suspected outbreak of illness, l Giardiasis l including, but not limited to, foodborne, l Hansen’s disease Chancroid l waterborne or nosocomial disease or a l Hemolytic uremic syndrome, post-diarrheal Chlamydia, including neonatal suspected act of bioterrorism l Hepatitis B, including newly diagnosed acute, conjunctivitis l l Pertussis perinatal and chronic infections, and pregnant Gonorrhea l l Plague women who have tested positive for Hep B Granuloma inguinale l l Poliomyelitis surface antigen Lymphogranuloma venereum l l Rabies (human illness) l Influenza-associated pediatric mortality Syphilis, all stages and congenital l Rubella l Legionellosis l SARS-CoV disease (SARS) l Listeriosis Tuberculosis (confirmed or suspect cases) l Smallpox l Lyme disease 609-826-4878 l Tularemia l Malaria Written report within 24 hours l Viral hemorrhagic fevers (including, but l Mumps not limited to, Ebola, Lassa, and Marburg l Psittacosis Occupational and Environmental viruses) l Q fever Diseases, Injuries, and Poisonings l Rocky Mountain spotted fever 609-826-4920 l Rubella, congenital syndrome Report within 30 days after Cases should be reported to the local health l Salmonellosis diagnosis or treatment l department where the patient resides. If Shigellosis l Work-related asthma (possible, l patient residence is unknown, report to your Staphylococcus aureus , with intermediate- probable, and confirmed) own local health department. Contact level resistance (VISA) or high-level- l Silicosis information is available at: localhealth.nj.gov. resistance (VRSA) to vancomycin only l Asbestosis l Streptococcal disease, invasive group A l Pneumoconiosis, other and unspecified l If the individual does not live in New Jersey, Streptococcal disease, invasive group B, l Extrinsic allergic alveolitis report the case to the New Jersey Department neonatal l Lead, mercury, cadmium, l of Health at: 609-826-5964. Streptococcal toxic shock syndrome arsenic toxicity in adults l Streptococcus pneumoniae , invasive disease l Work-related injury in l In cases of immediately reportable diseases Tetanus children (< age 18) l and other emergencies - if the local health Toxic shock syndrome (other than l Work-related fatal injury department cannot be reached - the New Streptococcal) l Occupational dermatitis l Jersey Department of Health maintains an Trichinellosis l Poisoning caused by known or l emergency after hours phone number: Typhoid fever suspected occupational exposure l 609-392-2020. Varicella (chickenpox) l Pesticide toxicity l Vibriosis l Work-related carpal tunnel syndrome l Viral encephalitis l Other occupational disease July 2013 l Yellow fever l www.nj.gov/health/cd Yersiniosis H5697.
Load more

Recommended publications
  • Parinaud's Oculoglandular Syndrome
    Tropical Medicine and Infectious Disease Case Report Parinaud’s Oculoglandular Syndrome: A Case in an Adult with Flea-Borne Typhus and a Review M. Kevin Dixon 1, Christopher L. Dayton 2 and Gregory M. Anstead 3,4,* 1 Baylor Scott & White Clinic, 800 Scott & White Drive, College Station, TX 77845, USA; [email protected] 2 Division of Critical Care, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA; [email protected] 3 Medical Service, South Texas Veterans Health Care System, San Antonio, TX 78229, USA 4 Division of Infectious Diseases, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA * Correspondence: [email protected]; Tel.: +1-210-567-4666; Fax: +1-210-567-4670 Received: 7 June 2020; Accepted: 24 July 2020; Published: 29 July 2020 Abstract: Parinaud’s oculoglandular syndrome (POGS) is defined as unilateral granulomatous conjunctivitis and facial lymphadenopathy. The aims of the current study are to describe a case of POGS with uveitis due to flea-borne typhus (FBT) and to present a diagnostic and therapeutic approach to POGS. The patient, a 38-year old man, presented with persistent unilateral eye pain, fever, rash, preauricular and submandibular lymphadenopathy, and laboratory findings of FBT: hyponatremia, elevated transaminase and lactate dehydrogenase levels, thrombocytopenia, and hypoalbuminemia. His condition rapidly improved after starting doxycycline. Soon after hospitalization, he was diagnosed with uveitis, which responded to topical prednisolone. To derive a diagnostic and empiric therapeutic approach to POGS, we reviewed the cases of POGS from its various causes since 1976 to discern epidemiologic clues and determine successful diagnostic techniques and therapies; we found multiple cases due to cat scratch disease (CSD; due to Bartonella henselae) (twelve), tularemia (ten), sporotrichosis (three), Rickettsia conorii (three), R.
    [Show full text]
  • Reportable Diseases and Conditions
    KINGS COUNTY DEPARTMENT of PUBLIC HEALTH 330 CAMPUS DRIVE, HANFORD, CA 93230 REPORTABLE DISEASES AND CONDITIONS Title 17, California Code of Regulations, §2500, requires that known or suspected cases of any of the diseases or conditions listed below are to be reported to the local health jurisdiction within the specified time frame: REPORT IMMEDIATELY BY PHONE During Business Hours: (559) 852-2579 After Hours: (559) 852-2720 for Immediate Reportable Disease and Conditions Anthrax Escherichia coli: Shiga Toxin producing (STEC), Rabies (Specify Human or Animal) Botulism (Specify Infant, Foodborne, Wound, Other) including E. coli O157:H7 Scrombroid Fish Poisoning Brucellosis, Human Flavivirus Infection of Undetermined Species Shiga Toxin (Detected in Feces) Cholera Foodborne Disease (2 or More Cases) Smallpox (Variola) Ciguatera Fish Poisoning Hemolytic Uremic Syndrome Tularemia, human Dengue Virus Infection Influenza, Novel Strains, Human Viral Hemorrhagic Fever (Crimean-Congo, Ebola, Diphtheria Measles (Rubeola) Lassa, and Marburg Viruses) Domonic Acid Poisoning (Amnesic Shellfish Meningococcal Infections Yellow Fever Poisoning) Novel Virus Infection with Pandemic Potential Zika Virus Infection Paralytic Shellfish Poisoning Plague (Specify Human or Animal) Immediately report the occurrence of any unusual disease OR outbreaks of any disease. REPORT BY PHONE, FAX, MAIL WITHIN ONE (1) WORKING DAY Phone: (559) 852-2579 Fax: (559) 589-0482 Mail: 330 Campus Drive, Hanford 93230 Conditions may also be reported electronically via the California
    [Show full text]
  • 2012 Case Definitions Infectious Disease
    Arizona Department of Health Services Case Definitions for Reportable Communicable Morbidities 2012 TABLE OF CONTENTS Definition of Terms Used in Case Classification .......................................................................................................... 6 Definition of Bi-national Case ............................................................................................................................................. 7 ------------------------------------------------------------------------------------------------------- ............................................... 7 AMEBIASIS ............................................................................................................................................................................. 8 ANTHRAX (β) ......................................................................................................................................................................... 9 ASEPTIC MENINGITIS (viral) ......................................................................................................................................... 11 BASIDIOBOLOMYCOSIS ................................................................................................................................................. 12 BOTULISM, FOODBORNE (β) ....................................................................................................................................... 13 BOTULISM, INFANT (β) ...................................................................................................................................................
    [Show full text]
  • Sexually Transmitted Diseases/Infections Chancroid
    Sexually Transmitted Diseases/Infections Chancroid Chancroid is a bacterial infection caused by Haemophilus ducreyi. It is spread by sexual contact and results in genital ulcers. Chancroid is a reportable genital ulcer condition that is rarely seen in North Carolina. When infection does occur, it is usually associated with sporadic outbreaks. Chancroid, as well as genital herpes and syphilis, is a risk factor in the transmission of HIV infection. Chancroid lesions may be difficult to distinguish from ulcers caused by genital herpes or syphilis. A physician must therefore diagnose the infection by excluding other diseases with similar symptoms. The combination of a painful genital ulcer and tender suppurative inguinal adenopathy suggests the diagnosis of chancroid. A probable diagnosis of chancroid, for both clinical and surveillance purposes, can be made if all of the following criteria are met: 1) the patient has one or more painful genital ulcers; 2) the patient has no evidence of T. pallidum infection by darkfield examination of ulcer exudate or by a serologic test for syphilis performed at least 7 days after onset of ulcers; 3) the clinical presentation, appearance of genital ulcers and, if present, regional lymphadenopathy are typical for chancroid; and 4) a test for HSV performed on the ulcer exudate is negative. A definitive diagnosis of chancroid requires the identification of H. ducreyi on special culture media that is not widely available from commercial sources; even when these media are used, sensitivity is less than 80 percent. No FDA- cleared PCR test for H. ducreyi is available in the United States, but such testing can be performed by clinical laboratories that have developed their own PCR test and have conducted a CLIA verification study.
    [Show full text]
  • Reportable Disease Surveillance in Virginia, 2013
    Reportable Disease Surveillance in Virginia, 2013 Marissa J. Levine, MD, MPH State Health Commissioner Report Production Team: Division of Surveillance and Investigation, Division of Disease Prevention, Division of Environmental Epidemiology, and Division of Immunization Virginia Department of Health Post Office Box 2448 Richmond, Virginia 23218 www.vdh.virginia.gov ACKNOWLEDGEMENT In addition to the employees of the work units listed below, the Office of Epidemiology would like to acknowledge the contributions of all those engaged in disease surveillance and control activities across the state throughout the year. We appreciate the commitment to public health of all epidemiology staff in local and district health departments and the Regional and Central Offices, as well as the conscientious work of nurses, environmental health specialists, infection preventionists, physicians, laboratory staff, and administrators. These persons report or manage disease surveillance data on an ongoing basis and diligently strive to control morbidity in Virginia. This report would not be possible without the efforts of all those who collect and follow up on morbidity reports. Divisions in the Virginia Department of Health Office of Epidemiology Disease Prevention Telephone: 804-864-7964 Environmental Epidemiology Telephone: 804-864-8182 Immunization Telephone: 804-864-8055 Surveillance and Investigation Telephone: 804-864-8141 TABLE OF CONTENTS INTRODUCTION Introduction ......................................................................................................................................1
    [Show full text]
  • Know Your Abcs: a Quick Guide to Reportable Infectious Diseases in Ohio
    Know Your ABCs: A Quick Guide to Reportable Infectious Diseases in Ohio From the Ohio Administrative Code Chapter 3701-3; Effective August 1, 2019 Class A: Diseases of major public health concern because of the severity of disease or potential for epidemic spread – report immediately via telephone upon recognition that a case, a suspected case, or a positive laboratory result exists. • Anthrax • Measles • Rubella (not congenital) • Viral hemorrhagic fever • Botulism, foodborne • Meningococcal disease • Severe acute respiratory (VHF), including Ebola virus • Cholera • Middle East Respiratory syndrome (SARS) disease, Lassa fever, Marburg • Diphtheria Syndrome (MERS) • Smallpox hemorrhagic fever, and • Influenza A – novel virus • Plague • Tularemia Crimean-Congo hemorrhagic infection • Rabies, human fever Any unexpected pattern of cases, suspected cases, deaths or increased incidence of any other disease of major public health concern, because of the severity of disease or potential for epidemic spread, which may indicate a newly recognized infectious agent, outbreak, epidemic, related public health hazard or act of bioterrorism. Class B: Disease of public health concern needing timely response because of potential for epidemic spread – report by the end of the next business day after the existence of a case, a suspected case, or a positive laboratory result is known. • Amebiasis • Carbapenemase-producing • Hepatitis B (perinatal) • Salmonellosis • Arboviral neuroinvasive and carbapenem-resistant • Hepatitis C (non-perinatal) • Shigellosis
    [Show full text]
  • Communicable Diseases Weekly Report
    Communicable Diseases Weekly Report Week 08, 21 February to 27 February 2021 In summary, we report: • Chancroid – one new case in a returned traveller • Rodent-borne disease risks • Novel coronavirus 2019 (COVID-19) • Summary of notifiable conditions activity in NSW For further information see NSW Health infectious diseases page. This includes links to other NSW Health infectious disease surveillance reports and a diseases data page for a range of notifiable infectious diseases. Chancroid One case of chancroid was notified this reporting week in a traveller returning from overseas. Chancroid is an acute sexually transmitted bacterial infection that causes painful genital ulcers. The condition is now rarely seen in Australia and only one other case has been notified in NSW during the past decade. Although the incidence of chancroid is decreasing globally, it is still reported in some regions within Africa, Asia, the Caribbean and South Pacific. Chancroid genital ulcer disease is a known risk factor for the transmission of HIV. The bacterium that causes chancroid, Haemophilus ducreyi, is usually transmitted through anal, oral, or vaginal sex with an infected person. After infection, one or more ulcers (sores) develop on the genitals or around the anus. Non-genital skin infections have also been reported globally, through non-sexual skin-to-skin contact with an infected person. The ulcers are usually painful, but rarely can be asymptomatic. Swelling in the groin (due to enlarged painful lymph nodes that can liquify and develop into buboes) can also occur. Other symptoms may include pain during sexual intercourse or while urinating. An infected person can spread the infection from their genital region to other parts of their body.
    [Show full text]
  • Annual Summary of Communicable Disease Reported to MDH, 2003
    MINNESOTA DEPARTMENT OF HEALTH DISEASE CONTROL N EWSLETTER Volume 32, Number 4 (pages 33-52) July/August 2004 Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2003 Introduction Minnesota Government Data Practices do not appear in Table 2 because the Assessment is a core public health Act (Section 13.38). Provisions of the influenza surveillance system is based function. Surveillance for communi- Health Insurance Portability and on reported outbreaks rather than on cable diseases is one type of ongoing Accountability Act (HIPAA) allow for individual cases. assessment activity. Epidemiologic routine communicable disease report- surveillance is the systematic collec- ing without patient authorization. Incidence rates in this report were tion, analysis, and dissemination of calculated using disease-specific health data for the planning, implemen- Since April 1995, MDH has participated numerator data collected by MDH and a tation, and evaluation of public health as one of the Emerging Infections standardized set of denominator data programs. The Minnesota Department Program (EIP) sites funded by the derived from U.S. Census data. of Health (MDH) collects disease Centers for Disease Control and Disease incidence may be categorized surveillance information on certain Prevention (CDC) and, through this as occurring within the seven-county communicable diseases for the program, has implemented active Twin Cities metropolitan area (Twin purposes of determining disease hospital- and laboratory-based surveil- Cities metropolitan area) or outside of it impact, assessing trends in disease lance for several conditions, including (Greater Minnesota). occurrence, characterizing affected selected invasive bacterial diseases populations, prioritizing disease control and food-borne diseases. Anaplasmosis efforts, and evaluating disease preven- Human anaplasmosis (HA) is the new tion strategies.
    [Show full text]
  • Disease Control Newsletter, July/August 2005
    MINNESOTA DEPARTMENT OF HEALTH D ISEASE C ONTROL N EWSLETTER Volume 33, Number 4 (pages 37-56) July/August 2005 Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2004 Introduction private and protected under the Incidence rates in this report were Assessment is a core public health Minnesota Government Data Practices calculated using disease-specific function. Surveillance for communi­ Act (Section 13.38). Provisions of the numerator data collected by MDH and a cable diseases is one type of assess­ Health Insurance Portability and standardized set of denominator data ment. Epidemiologic surveillance is the Accountability Act (HIPAA) allow for derived from U.S. Census data. systematic collection, analysis, and routine communicable disease report­ Disease incidence may be categorized dissemination of health data for the ing without patient authorization. as occurring within the seven-county planning, implementation, and evalua­ Twin Cities metropolitan area or outside tion of health programs. The Minnesota Since April 1995, MDH has participated of it (Greater Minnesota). Department of Health (MDH) collects as an Emerging Infections Program information on certain communicable (EIP) site funded by the Centers for Anaplasmosis diseases for the purposes of determin­ Disease Control and Prevention (CDC) Human anaplasmosis (HA) is the new ing disease impact, assessing trends in and, through this program, has imple­ nomenclature for the disease formerly disease occurrence, characterizing mented active hospital- and laboratory- known as human granulocytic affected populations, prioritizing control based surveillance for several condi­ ehrlichiosis. HA (caused by the efforts, and evaluating prevention tions, including selected invasive rickettsia Anaplasma phagocytophilum) strategies. Prompt reporting allows bacterial diseases and food-borne is transmitted to humans by Ixodes outbreaks to be recognized in a timely diseases.
    [Show full text]
  • Sexually Transmitted Infections Introduction and General Considerations Date Reviewed: July, 2010 Section: 5-10 Page 1 of 13
    Sexually Transmitted Infections Introduction and General Considerations Date Reviewed: July, 2010 Section: 5-10 Page 1 of 13 Background Information The incidence of Sexually Transmitted Infections (STIs) in Saskatchewan has been increasing over the past number of years. This may be due in part to the introduction of testing procedures that are easier to complete and less invasive. In Saskatchewan, the rates for chlamydia have been among the highest in Canada. Refer to http://dsol- smed.phac-aspc.gc.ca/dsol-smed/ndis/c_indp_e.html#c_prov for historical surveillance data collected by Public Health Agency of Canada (PHAC). STIs are transmitted in the context of other social and health challenges; the risk of recurrent exposure and infection are likely unless these underlying issues are dealt with. A holistic assessment of clients assists in identifying these underlying issues and a multidisciplinary team approach is often necessary and should involve other partners such as physicians, addiction services and mental health as required. The regulations of The Health Information Protection Act must be adhered to when involving other partners in the management of individuals or when referring individuals to other agencies. This section highlights some of the general and special considerations that should be kept in mind when conducting STI investigations. It also highlights key points and summarizes the Canadian Guidelines on Sexually Transmitted Infections which can be located at http://www.phac-aspc.gc.ca/std-mts/sti-its/guide-lignesdir-eng.php. Reporting Requirements Index cases must be reported to the Ministry of Health. See Reporting Requirements in the General Information section of this manual for additional information and guidelines.
    [Show full text]
  • Lymphogranuloma Venereum (LGV) Reporting and Case Investigation
    Public Health and Primary Health Care Communicable Disease Control 4th Floor, 300 Carlton St, Winnipeg, MB R3B 3M9 T 204 788-6737 F 204 948-2040 www.manitoba.ca November, 2015 Re: Lymphogranuloma Venereum (LGV) Reporting and Case Investigation Reporting of LGV (Chlamydia trachomatis L1, L2 and L3 serovars) is as follows: Laboratory: All positive laboratory results for Chlamydia trachomatis L1, L2 and L3 serovars are reportable to the Public Health Surveillance Unit by secure fax (204-948- 3044). Health Care Professional: For Public Health investigation and to meet the requirement for contact notification under the Reporting of Diseases and Conditions Regulation in the Public Health Act, the Notification of Sexually Transmitted Disease (NSTD) form ( http://www.gov.mb.ca/health/publichealth/cdc/protocol/form3.pdf ) must be completed for all laboratory-confirmed cases of LGV. Please check with the public health office in your region with respect to procedures for return of NSTD forms for case and contact investigation. Cooperation with Public Health investigation is appreciated. Regional Public Health or First Nations Inuit Health Branch: Return completed NSTD forms to the Public Health Surveillance Unit by mail (address on form) or secure fax (204-948-3044). Sincerely, “Original Signed By” “Original Signed By” Richard Baydack, PhD Carla Ens, PhD Director, Communicable Disease Control Director, Epidemiology & Surveillance Public Health and Primary Health Care Public Health and Primary Health Care Manitoba Health, Healthy Living and Seniors Manitoba Health, Healthy Living and Seniors Communicable Disease Management Protocol Lymphogranuloma Venereum (LGV) Communicable Disease Control Unit Etiology distinct stages (2, 9). Primary infection appears three to 30 days after infection (2, 8) and presents LGV is caused by Chlamydia trachomatis (C.
    [Show full text]
  • Laboratory Diagnosis of Sexually Transmitted Infections, Including Human Immunodeficiency Virus
    Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus human immunodeficiency including Laboratory transmitted infections, diagnosis of sexually Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus Editor-in-Chief Magnus Unemo Editors Ronald Ballard, Catherine Ison, David Lewis, Francis Ndowa, Rosanna Peeling For more information, please contact: Department of Reproductive Health and Research World Health Organization Avenue Appia 20, CH-1211 Geneva 27, Switzerland ISBN 978 92 4 150584 0 Fax: +41 22 791 4171 E-mail: [email protected] www.who.int/reproductivehealth 7892419 505840 WHO_STI-HIV_lab_manual_cover_final_spread_revised.indd 1 02/07/2013 14:45 Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus Editor-in-Chief Magnus Unemo Editors Ronald Ballard Catherine Ison David Lewis Francis Ndowa Rosanna Peeling WHO Library Cataloguing-in-Publication Data Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus / edited by Magnus Unemo … [et al]. 1.Sexually transmitted diseases – diagnosis. 2.HIV infections – diagnosis. 3.Diagnostic techniques and procedures. 4.Laboratories. I.Unemo, Magnus. II.Ballard, Ronald. III.Ison, Catherine. IV.Lewis, David. V.Ndowa, Francis. VI.Peeling, Rosanna. VII.World Health Organization. ISBN 978 92 4 150584 0 (NLM classification: WC 503.1) © World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO web site (www.who.int/about/licensing/copyright_form/en/index.html).
    [Show full text]